Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi Study原发性胆汁性胆管炎患者提问提示清单的开发：一项德尔菲研究Clinical Gastroenterology and HepatologyIF122025-04-150OAAI
Histologic stage is a stronger predictor of transplant free survival than APRI and FIB-4 in patients with primary biliary cholangitisJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Stratification of hepatocellular carcinoma risk using the GLOBE score in patients with primary biliary cholangitis-the Global PBC Study GroupJOURNAL OF HEPATOLOGYIF332018-04-010OAAI
Glecaprevir/pibrentasvir in patients with hepatitis C and prior treatment experience: an integrated phase II/III analysisJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Younger age is associated with lower transplant-free survival relative to a general population in patients with Primary Biliary CholangitisJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Characterization of patients with Both Alcoholic and Nonalcoholic Fatty Liver Disease (BAFLD) in a large United States cohortJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Ursodeoxycholic acid treatment is associated with prolonged transplant-free survival in primary biliary cholangitis - even in patients without biochemical improvementsJOURNAL OF HEPATOLOGYIF332018-04-014PREAI
A dose-response relationship in the association between ursodeoxycholic acid treatment and prolonged transplant-free survival in primary biliary cholangitisJOURNAL OF HEPATOLOGYIF332018-04-010OAAI
Elbasvir/Grazoprevir effectiveness in patients with Chronic Hepatitis C and Chronic Kidney Disease: real-world experience from the TRIO NetworkJOURNAL OF HEPATOLOGYIF332017-01-012PREAI
Increase in age at diagnosis of Primary Biliary Cholangitis over the last 40 yearsJOURNAL OF HEPATOLOGYIF332017-01-011PREAI
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death in different age-categories over timeJOURNAL OF HEPATOLOGYIF332017-01-013PREAI
Real-world use of elbasvir/grazoprevir and outcomes in patients with chronic hepatitis C: retrospective data analyses from the TRIO NetworkJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
High efficacy is accompanied with substantial gains in patient reported outcomes in cirrhotic patients with chronic hepatitis C treated with sofosbuvir (SOF), velpatasvir with or without voxilaprevir (VOX): data from POLARIS 1, 2, 3 and 4JOURNAL OF HEPATOLOGYIF332017-01-011PREAI
Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) CohortJOURNAL OF HEPATOLOGYIF332017-01-011PREAI
PREDICTORS OF IMPROVEMENT IN NAFLD ACTIVITY SCORE ON PLACEBO: A SECONDARY ANALYSIS OF THE FLINT TRIALJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
BEHAVIORAL PATTERNS OF TOTAL SERUM BILIRUBIN PRIOR TO MAJOR CLINICAL ENDPOINTS IN 3529 PATIENTS WITH PRIMARY BILIARY CHOLANGITISJOURNAL OF HEPATOLOGYIF332016-01-014PREAI
NO EFFECT OF PROTON PUMP INHIBITOR (PPI) USE ON SVR WITH LEDIPASVIR/SOFOSBUVIR (LDV/SOF): REALWORLD DATA FROM 2034 GENOTYPE 1 PATIENTS IN THE TRIO NETWORKJOURNAL OF HEPATOLOGYIF332016-01-018PREAI
CORRELATIONS BETWEEN HEPATIC MORPHOMETRIC COLLAGEN CONTENT, HISTOLOGIC FIBROSIS STAGE, AND SERUM MARKERS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)JOURNAL OF HEPATOLOGYIF332016-01-012PREAI
EVALUATION OF EFFECTS OF CONCOMITANT MEDICATIONS FOR NON-ALCOHOLIC STEATOHEPATITIS AND ASSOCIATED COMORBIDITIES ON HISTOLOGICAL IMPROVEMENTS WITH OBETICHOLIC ACIDJOURNAL OF HEPATOLOGYIF332016-01-011PREAI
RISK FACTORS FOR HEPATIC DECOMPENSATION IN PRIMARY BILIARY CIRRHOSIS - RESULTS OF AN INTERNATIONAL FOLLOW UP STUDY OF 2326 PATIENTSJOURNAL OF HEPATOLOGYIF332015-04-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向